98 related articles for article (PubMed ID: 16437871)
1. Multidisciplinary approach to locally advanced rectal cancer: results of a single institution trial.
Delrio P; Avallone A; Guida C; Lastoria S; Tatangelo F; Cascini GM; Marone P; Petrillo A; Budillon A; Di Marzo M; Palaia R; Albino V; De Rosa V; Parisi V
Suppl Tumori; 2005; 4(3):S8. PubMed ID: 16437871
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
3. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
4. Combined multistep approach in a locally advanced rectal cancer with sacral invasion: case report.
Delrio P; Fazioli F; Di Marzo M; Avallone A; Elmo M; Pecori B; Ravo V; Idà DN; Bianchi P; Cremona F; De Rosa V; Parisi V
Suppl Tumori; 2005; 4(3):S7. PubMed ID: 16437870
[TBL] [Abstract][Full Text] [Related]
5. Role of combined-modality therapy in the management of locally advanced rectal cancer.
Hosein PJ; Rocha-Lima CM
Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689
[TBL] [Abstract][Full Text] [Related]
6. Locally advanced rectal cancer: what is the evidence for induction chemoradiation?
Glynne-Jones R; Harrison M
Oncologist; 2007 Nov; 12(11):1309-18. PubMed ID: 18055850
[TBL] [Abstract][Full Text] [Related]
7. T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.
Martijnse IS; Dudink RL; Kusters M; Vermeer TA; West NP; Nieuwenhuijzen GA; van Lijnschoten I; Martijn H; Creemers GJ; Lemmens VE; van de Velde CJ; Sebag-Montefiore D; Glynne-Jones R; Quirke P; Rutten HJ
Ann Surg Oncol; 2012 Feb; 19(2):392-401. PubMed ID: 21792506
[TBL] [Abstract][Full Text] [Related]
8. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
Gollins S
Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
[TBL] [Abstract][Full Text] [Related]
9. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
10. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
[TBL] [Abstract][Full Text] [Related]
11. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
12. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
[TBL] [Abstract][Full Text] [Related]
14. Have the changes in treatment of rectal cancer made a significant difference to our patients?
Benson AB; Guillem JG; Minsky BD
Oncology (Williston Park); 2011 Dec; 25(14):1323-9. PubMed ID: 22329182
[TBL] [Abstract][Full Text] [Related]
15. Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer.
Tan J; Heriot AG; Mackay J; Van Dyk S; Bressel MA; Fox CD; Hui AC; Lynch AC; Leong T; Ngan SY
J Med Imaging Radiat Oncol; 2013 Oct; 57(5):617-25. PubMed ID: 24119279
[TBL] [Abstract][Full Text] [Related]
16. Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer.
Habr-Gama A; Perez R; Proscurshim I; Gama-Rodrigues J
Surg Oncol Clin N Am; 2010 Oct; 19(4):829-45. PubMed ID: 20883957
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy in pelvic recurrences of rectal cancer].
Morganti AG; Santoni R; Osti MF
Ann Ital Chir; 2001; 72(5):585-94. PubMed ID: 11975414
[TBL] [Abstract][Full Text] [Related]
18. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Daniel ES; Gibbs P; Guerrieri M; Faragher I
Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
[TBL] [Abstract][Full Text] [Related]
20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
